Free Trial
→ The chokepoint supplier behind SpaceX's $1.75 trillion empire (From Behind the Markets) (Ad)tc pixel Free BBC Stock Alerts

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Short Interest Ratio & Short Volume

$44.92 +0.11 (+0.25%)
As of 04:10 PM Eastern
Compare

Virtus LifeSci Biotech Clinical Trials ETF Short Interest Overview

As of April 15, 2026, Virtus LifeSci Biotech Clinical Trials ETF (BBC) had a short interest of 83,305 shares sold short, representing 10.41% of the public float. This marks a 72.09% increase in short interest since the prior report. The short interest ratio (days to cover) is 5.5, meaning it would take 5.5 days of the average trading volume of 22,574 shares to cover all short positions.

Current Short Interest
83,305 shares
Previous Short Interest
48,409 shares
Change Vs. Previous Month
72.09%
Dollar Volume Sold Short
$3.83 million
Short Interest Ratio
5.5 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
850,000 shares
Short Percent of Float
10.41%
Today's Trading Volume
16,873 shares
Average Trading Volume
22,574 shares
Today's Volume Vs. Average
75%
Short Selling Virtus LifeSci Biotech Clinical Trials ETF?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BBC Short Interest Over Time

BBC Days to Cover Over Time

BBC Percentage of Float Shorted Over Time

Virtus LifeSci Biotech Clinical Trials ETF Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202683,305 shares $3.83 million +72.1%10.4%5.45 $45.98
3/31/202648,409 shares $2.01 million +19.9%6.1%2.73 $41.62
3/13/202640,393 shares $1.64 million -0.5%4.5%2 $40.65
2/27/202640,613 shares $1.72 million +122.7%4.5%2.13 $42.47
2/13/202618,241 shares $727.27 thousand +34.9%2.0%0.74 $39.87
1/30/202613,527 shares $552.44 thousand +55.1%1.5%0.65 $40.84
1/15/20268,723 shares $352.06 thousand +1.1%1.0%0.25 $40.36
12/31/20258,630 shares $332.77 thousand -75.5%1.0%0.33 $38.56
12/15/202535,213 shares $1.40 million +165.4%5.4%0.92 $39.80
11/28/202513,267 shares $501.89 thousand -46.5%2.0%0.51 $37.83
11/14/202524,809 shares $802.32 thousand +23.8%3.8%1.68 $32.34
10/31/202520,036 shares $646.36 thousand -3.7%3.1%1.04 $32.26
10/15/202520,800 shares $637.52 thousand +57.6%3.2%1.2 $30.65
9/30/202513,200 shares $360.36 thousand +10.0%N/A0.7 $27.30
9/15/202512,000 shares $288 thousand -0.8%N/A0.4 $24.00
8/31/202512,100 shares $274.67 thousand -32.4%1.7%0.4 $22.70
8/15/202517,900 shares $410.81 thousand -31.7%N/A0.5 $22.95
7/31/202526,200 shares $567.49 thousand +359.7%3.7%0.6 $21.66
7/15/20255,700 shares $120.10 thousand -70.9%N/A0.1 $21.07
6/30/202519,600 shares $378.67 thousand +575.9%3.6%0.3 $19.32
6/15/20252,900 shares $57.57 thousand -71.8%0.4%0 $19.85
5/31/202510,300 shares $187.67 thousand -78.5%2.1%0.1 $18.22
5/15/202547,800 shares $836.50 thousand +212.4%N/A0.6 $17.50
4/30/202515,300 shares $292.08 thousand -57.4%N/A0.2 $19.09
4/15/202535,900 shares $591.63 thousand +165.9%N/A0.6 $16.48
3/14/2025600 shares $11.97 thousand -25.0%N/A0 $19.95
2/28/2025800 shares $16.27 thousand -60.0%N/A0.2 $20.34
2/14/20252,000 shares $44.66 thousand -61.5%N/A0.6 $22.33
1/31/20255,200 shares $119.70 thousand +10.6%N/A1.7 $23.02
1/15/20254,700 shares $104.53 thousand -4.1%N/A1.7 $22.24

BBC Short Interest - Frequently Asked Questions

What is Virtus LifeSci Biotech Clinical Trials ETF's current short interest?

Short interest is the volume of Virtus LifeSci Biotech Clinical Trials ETF shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 83,305 shares of BBC short. 10.41% of Virtus LifeSci Biotech Clinical Trials ETF's shares are currently sold short. Learn More on Virtus LifeSci Biotech Clinical Trials ETF's current short interest.

What is a good short interest ratio for Virtus LifeSci Biotech Clinical Trials ETF?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BBC shares currently have a short interest ratio of 5.5. Learn More on Virtus LifeSci Biotech Clinical Trials ETF's short interest ratio.

Which institutional investors are shorting Virtus LifeSci Biotech Clinical Trials ETF?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Virtus LifeSci Biotech Clinical Trials ETF: Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Virtus LifeSci Biotech Clinical Trials ETF?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.41% of Virtus LifeSci Biotech Clinical Trials ETF's floating shares are currently sold short.

Is Virtus LifeSci Biotech Clinical Trials ETF's short interest increasing or decreasing?

Virtus LifeSci Biotech Clinical Trials ETF saw a increase in short interest in April. As of April 15th, there was short interest totaling 83,305 shares, an increase of 72.1% from the previous total of 48,409 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Virtus LifeSci Biotech Clinical Trials ETF's short interest compare to its competitors?

10.41% of Virtus LifeSci Biotech Clinical Trials ETF's shares are currently sold short. Here is how the short interest of companies compare to Virtus LifeSci Biotech Clinical Trials ETF: Harbor Health Care ETF (0.20%), Global X HealthTech ETF (0.74%), Horizon Kinetics Medical ETF (0.61%), Direxion Daily Pharmaceutical & Medical Bull 3X Shares (2.22%), Invesco Nasdaq Biotechnology ETF (1.05%), ProShares UltraShort Health Care (1.60%), ProShares UltraShort Nasdaq Biotechnology (5.08%), ProShares Ultra Health Care (0.06%), Simplify Propel Opportunities ETF (0.02%), ProShares Ultra Nasdaq Biotechnology (1.10%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short Virtus LifeSci Biotech Clinical Trials ETF stock?

Short selling BBC is an investing strategy that aims to generate trading profit from Virtus LifeSci Biotech Clinical Trials ETF as its price is falling. BBC shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Virtus LifeSci Biotech Clinical Trials ETF?

A short squeeze for Virtus LifeSci Biotech Clinical Trials ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBC, which in turn drives the price of the stock up even further.

How often is Virtus LifeSci Biotech Clinical Trials ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBC, twice per month. The most recent reporting period available is April, 15 2026.

What do BBC's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like BBC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (NYSEARCA:BBC) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel